Status:

RECRUITING

Safety and Efficacy Study Using 5-ALA Oral Administration as an Adjuvant Therapy on the Rate of Local Tumor Recurrence in Patients Who Have Desmoids Tumors

Lead Sponsor:

michal roll

Conditions:

The Aim of the Study is to Evaluate the Efficacy of Photodynamic Therapy as an

Adjuvant Therapy on the Clinical Outcome of Patients With Desmoid Tumors After

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

The purpose of this study is to evaluate the efficacy of preoperative 5-ALA oral administration and subsequently intraoperative tumor bed phototherapy with red light laser, as an adjuvant therapy on t...

Eligibility Criteria

Inclusion

  • Patient has a resectable histologically confirmed desmoid tumor.
  • Previously treated (by chemotherapy, irradiation or surgery) patients are eligible.
  • Age \> 18 years
  • Signed informed consent prior to patient recruitment. -

Exclusion

  • Hepatic enzymes or bilirubin \> 2X upper limit of normal.
  • Serum creatinine \> 2.5 x upper limit of normal.
  • Suspected /documented metastatic disease.
  • Active or uncontrolled infections.
  • Active second malignant disease (excluding non-melanoma skin cancer, or in situ cervix or breast carcinoma) \< 2 years prior to the study.
  • Use of other investigational agents \< 30 days prior to the study.
  • Patients who are mentally or physically unable to comply with all aspects of the study.
  • Any serious medical condition, including the presence of laboratory abnormalities, which places the subject at an unacceptable risk if he or she participates in this study or confounds the experimental ability to interpret data from the study.
  • Pregnant or lactating females.
  • Known intolerance or allergy to 5-ALA
  • Suspicious or documented acute or chronic porphyria

Key Trial Info

Start Date :

June 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2026

Estimated Enrollment :

140 Patients enrolled

Trial Details

Trial ID

NCT01898416

Start Date

June 1 2013

End Date

December 1 2026

Last Update

October 31 2013

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Tel Aviv sourasky medical center

Tel Aviv, Israel, Israel, 64239

2

The Aviv Sourasky Medical Center

Tel Aviv, Israel, Israel, 64239